WILLIAM YETTER: Open Payments
NPI 1346212230 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,958 in 119 payments from 9 companies in 2025. Trend: 2023 $46,752 · 2024 $80,548 · 2025 $27,958
Consulting: $12,375Speaker / faculty: $9,460Food & beverage: $3,736Travel & lodging: $2,388
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $15,214 |
| E.R. Squibb & Sons, L.L.C. | 49 | $11,698 |
| Teva Pharmaceuticals USA, Inc. | 29 | $650 |
| Alkermes, Inc. | 4 | $233 |
| Janssen Pharmaceuticals, Inc | 2 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| ABBVIE INC. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, COBENFY, UZEDY, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA, Qelbree, INGREZZA.
Industry payments across VA — which companies pay providers there.
